Arthritis patients may ditch IV drips for home shots
NCT ID NCT05424926
First seen Nov 01, 2025 · Last updated May 06, 2026 · Updated 23 times
Summary
This study tested whether people with rheumatoid, psoriatic, or spine arthritis could safely switch from receiving infliximab through an IV at the hospital to giving themselves a simple injection at home every two weeks. 22 adults who were already stable on IV infliximab were offered the switch and followed for 6 months. The main goal was to see how many stayed on the new at-home treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rheumatology Department, Cochin Hospital
Paris, IDF, 75014, France
Conditions
Explore the condition pages connected to this study.